Without insurance, weight-loss shots usually cost $349–$499 monthly through maker programs; list prices often exceed $1,000 per month.
Cash prices for modern weight-loss injections vary a lot by brand, dose, and where you buy. The headline: direct self-pay programs from manufacturers now anchor many monthly totals near $349–$499, while standard list prices still sit above $1,000. Below you’ll find clear ranges, real program numbers, and what adds to the bill so you can plan your spend with fewer surprises.
Fast Price Snapshot By Brand
These are typical self-pay ranges seen across major brands in the United States. Your local pharmacy quote can differ, but manufacturer programs have made pricing more consistent.
| Medication | Typical Self-Pay Monthly Price | Usual List Price Context |
|---|---|---|
| Semaglutide (Wegovy) | $499/month via Novo Nordisk’s direct program (all strengths) | Historic list price ≈ $1,350 per 28-day pack |
| Tirzepatide (Zepbound) | $349 for 2.5 mg vials; $499 for 5 mg; 7.5–10 mg can price at $499 with timely refills | List price previously near $1,086/month |
| Liraglutide (Saxenda) | Often quoted near $1,300 without program help; deals vary | Historically above $1,000/month cash |
What Do Weight-Loss Shots Cost Without Health Coverage?
Expect a spread. Direct self-pay programs from the makers set anchor pricing at $349–$499 per month for popular weekly injectables. Pharmacy cash quotes and older daily options often run higher. The main drivers are dose strength, supply format (pens vs. vials), and whether you buy through a manufacturer channel or a traditional pharmacy counter.
How The Big Programs Price Monthly
Novo Nordisk now offers a direct cash price of $499 per month for semaglutide across dose strengths through its patient program, as widely reported by major outlets in 2025. Newsrooms also covered temporary first-month specials earlier in the year and broader moves to curb spending on copycat products. These changes followed supply stabilization and a push to route buyers to FDA-approved sources. Coverage from Reuters on Novo Nordisk pricing steps explains the shift and the $499/month landing point for ongoing fills.
Eli Lilly’s program for tirzepatide vials advertises tiered cash pricing: $349/month for the 2.5 mg start, $499/month for 5 mg, and options to keep 7.5–10 mg at $499 with timely refills. These details appear in Lilly announcements and coverage that summarize the self-pay “Journey” structure. See the company’s release and financial press summaries of the same pricing.
Where Older Daily Options Land
Daily liraglutide often remains near four-figure monthly cash totals at many retail counters. Third-party pricing roundups through 2025 show quotes around $1,300 per month when no savings apply. Figures differ by city and pharmacy chain, and occasional deals appear through telehealth vendors.
Why The Same Drug Can Show Different Cash Totals
Three levers set your bill:
- Program Channel: Many buyers now fill directly through maker-run pharmacies that bundle delivery and refill reminders. Traditional counters may quote higher cash prices unless they honor a program route or discount network.
- Dose Step-Up: Weekly products start low and rise in steps. Entry tiers can be cheaper than mid or high tiers unless the program locks a flat monthly price.
- Vials vs. Pens: Vials with standard needles can shave dollars off compared with pens. That said, pens are simpler to use and track.
Sample Monthly Budgets (No Insurance)
These examples show how costs stack with common add-ons like visits and labs. Swap any item to match your clinic or telehealth setup.
Lean Clinic Setup
- Medication: $499 (semaglutide program price)
- Clinic follow-up: $50–$100 (brief check-in)
- Supplies: $0–$15 (alcohol swabs, sharps container)
Estimated month: $549–$614
Vial Route With Step-Up
- Medication: $349 to start tirzepatide; $499 once at 5 mg
- Telehealth membership: $20–$40
- First-month labs: $25–$75 (if not recently done)
Estimated month: $394–$614 at maintenance
Program Details Worth Reading
Cash programs can include dose-specific rules, refill windows, and home delivery. Lilly highlights that refills within a set window keep some doses at $499; outside that window, pricing can rise on the next shipment. Company statements outline the tiers and refill timing.
Novo Nordisk messaging around $499/month spans all dose strengths and aims to route buyers to authentic, FDA-approved product rather than compounded copies. Multiple outlets covered the policy and timing across spring and summer 2025.
Beware Of Compounded Copies
Cheaper compounded versions have drawn safety alerts and enforcement deadlines. The regulator cautioned about dosing errors and product quality in non-approved compounded semaglutide, and set timelines for compounders to stop producing certain versions as shortages eased. Review the FDA compounding alert and coverage summarizing the stop-dates for copycat tirzepatide products.
What Else Adds To The Bill
Medication is the base. A few small items can change the month-to-month total:
- Visits: In-person clinics often bundle quick checks; telehealth platforms bill short virtual follow-ups.
- Labs: Some prescribers request baseline labs and repeat checks during dose changes.
- Supplies: Alcohol swabs, a sharps container, and spare pen needles if you use pens.
Common Add-Ons And Typical Ranges
| Line Item | Typical Range | Notes |
|---|---|---|
| Clinic/Telehealth Follow-Up | $20–$150 | Short visits run lowest; bundled plans vary |
| Baseline Or Update Labs | $25–$125 | Cash labs or insurance-billed if you have limited coverage |
| Supplies | $0–$20 | Swabs, sharps container; pens may need spare needles |
Brand-By-Brand Notes
Semaglutide Weekly Pens
Direct cash routes promote a flat $499/month across strengths. Newsrooms detailed a first-month special earlier in 2025 and the steady ongoing price that followed. Retail counters and discount cards sometimes show higher quotes, which is why many cash buyers now choose the direct route.
Tirzepatide Vials
Entry vials commonly price at $349/month, then $499/month as you move to 5 mg. With timely refills, some mid doses can stay at $499. This tiering appears in company statements and financial press write-ups.
Liraglutide Daily Pens
Daily dosing and older supply chains keep many cash quotes high. Roundups through 2025 still show near-list totals at many counters unless a special rate or membership lowers the bill.
How Dose Escalation Changes Monthly Spend
Weekly products start at a gentle dose, then step up over weeks. If your program prices the same at any dose, your month stays steady. If pricing is dose-linked, your month can rise as you move up. That’s why many people see $349 for the first month on a vial route and $499 once at a standard maintenance tier.
Ways To Keep Costs Predictable
- Use The Official Cash Channel: Many buyers save by enrolling in the maker’s direct program rather than paying a random retail quote.
- Refill On Time: Some vial tiers stay at a lower rate only if you refill within a set window.
- Ask About Format: Pens are simpler; vials can cost less. Pick the route that fits your budget and comfort.
- Plan Visits: Stack quick check-ins during dose steps to avoid extra appointments.
Safety And Authenticity
Stick with FDA-approved products from trusted channels. Alerts describe dosing errors and product quality issues tied to compounded copies. As shortage pressures eased, the regulator set stop-dates for copycat versions of certain GLP-1s. That’s another reason many buyers choose official programs. Review the FDA notice and timeline coverage.
Plain-English Takeaway On Cash Pricing
If you’re paying cash for a weekly option, plan on $349–$499 per month through a manufacturer program, plus a small cushion for visits, labs, and supplies. Older daily options can still land near $1,300 per month without a deal. Direct programs and on-time refills are the two biggest levers most people can pull to keep bills steady.